Related Experiment Videos
[Treatment of lumbar disk hernias using chemonucleolysis]
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires
|July 1, 1982
Summary
Chemonucleolysis effectively treats herniated lumbar discs in 69% of patients, offering a safe alternative to surgery. Success rates are higher in younger patients with less severe disc collapse and smaller hernias.
Area of Science:
- Minimally Invasive Spine Procedures
- Interventional Pain Management
- Orthopedic Surgery
Context:
- Herniated lumbar discs are a common cause of low back pain and sciatica.
- Traditional treatments include conservative management and surgery.
- Chemonucleolysis offers a less invasive alternative for selected patients.
Purpose:
- To evaluate the efficacy and safety of chemonucleolysis for treating herniated lumbar discs.
- To identify factors influencing treatment success and failure.
- To assess the impact of chemonucleolysis on patient outcomes and subsequent surgical options.
Summary:
- This study reviewed 46 cases of herniated lumbar discs treated with chemonucleolysis.
- The procedure, performed under neuroleptanalgesia, showed a 69% success rate.
- Factors like patient age, symptom duration, disc collapse, and hernia size influenced outcomes. Tolerance was excellent, and failed cases did not preclude subsequent surgery.
Impact:
- Chemonucleolysis provides a viable, safe, and effective treatment option for carefully selected patients with herniated lumbar discs.
- The findings support chemonucleolysis as a valuable tool in the spine treatment armamentarium.
- This minimally invasive approach can potentially reduce the need for more invasive surgical interventions.